Russia increases exports of anti-COVID-19 vaccines this year

8 November 2021
coronavirus_credit_deposit_photos-_largre

Russia is increasing exports of its anti-COVID-19 vaccines this year, with the biggest markets being Argentina, Kazakhstan and India, reports The Pharma Letter’s local correspondent.

According to data of the Federal Customs Service, in the first eight months of the current year Russia exported 362.5 tons of vaccines worth $713.7 million.

It is reported that the majority of supplies were accounted for by Russia’s flagship Sputnik V vaccine, which so far has already been approved in 70 countries and fully meets the domestic demand.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical